Top 20 Largest Pharmaceutical Company Settlements, 1991-2010

Top 20 Largest Pharmaceutical Company Settlements, 1991-2010

Company;  Total Penalty;  Violation(s);  Year;  Major Drug Products Involved;  Laws Allegedly Violated (if applicable)
 

  • GlaxoSmithKline; $3.4 billion; Financial Violation; 2006.
  • Pfizer; $2.3 billion; Unlawful Promotion / Kickbacks; 2009; Bextra / Geodon / Zyvox / Lyrica; False Claims Act / Food, Drug, and Cosmetics Act.
  • Eli Lilly; $1.4 billion; Unlawful Promotion; 2009; Zyprexa; False Claims Act / Food, Drug, and Cosmetics Act. 
  • TAP Pharmaceutical Products; $875 million; Overcharging Govt Health Programs / Kickbacks; 2001; Lupron; False Claims Act / Prescription Drug Marketing Act.   
  • GlaxoSmithKline; $750 million; Poor Manufacturing Practices; 2010; Kytril / Bactroban / Paxil CR / Avandamet; False Claims Act / Food, Drug, and Cosmetics Act.
  • Serono; $704 million; Unlawful Promotion / Kickbacks / Monopoly Practices; 2005; Serostim; False Claims Act.     
  • Merck; $650 million; Overcharging Govt Health Programs / Kickbacks; 2008; Zocor / Vioxx / Pepcid; False Claims Act / Medicaid Rebate Statute.     
  • Purdue; $601 million; Unlawful Promotion; 2007; Oxycontin; False Claims Act.   
  • Allergan; $600 million; Unlawful Promotion; 2010; Botox; False Claims Act / Food, Drug, and Cosmetics Act.    
  • AstraZeneca; $520 million; Unlawful Promotion / Kickbacks; 2010; Seroquel; False Claims Act.    
  • Bristol‐MyersSquibb; $515 million; Unlawful Promotion / Kickbacks / Overcharging Govt Health Programs; 2007; Abilify / Serzone; False Claims Act / Food, Drug, and Cosmetics Act.    
  • Schering‐Plough; $500 million; Poor Manufacturing Practices; 2002; Claritin; FDA Current Good Manufacturing Practices.    
  • Schering‐Plough; $435 million; Unlawful Promotion / Kickbacks / Overcharging Govt Health Programs; 2006; Temodar / Intron A / K‐Dur / Claritin RediTabs; False Claims Act / Food, Drug, and Cosmetics Act.    
  • Pfizer; $430 million; Unlawful Promotion; 2004; Neurontin; False Claims Act / Food,Drug, and Cosmetics Act.      
  • Cephalon; $425 million; Unlawful Promotion; 2008; Actiq / Gabatril / Provigil; False Claims Act / Food, Drug, and Cosmetics Act.    
  • Novartis; $423 million; Unlawful Promotion / Kickbacks; 2010; Trileptal; False Claims Act / Food, Drug, and Cosmetics Act.    
  • AstraZeneca; $355 million; Overcharging Govt Health Programs; 2003; Zoladex; Prescription Drug Marketing Act.    
  • Schering‐Plough; $345 million; Overcharging Govt Health Programs / Kickbacks; 2004; Claritin; False Claims Act / Anti‐Kickback Statute.    
  • Forest Laboratories; $313 million; Unlawful Promotion / Concealing Study Findings / Kickbacks / Illegal Distribution; 2010; Levothyroid /Celexa / Lexapro; False Claims Act / Food, Drugs, and Cosmetics Act.    
  • Johnson & Johnson (State settlement); $258 million; Unlawful Promotion; 2010; Risperdal; Medical Assistance Program Integrity Law.

This list of Top 20 Largest Pharmaceutical Company Settlements is located in:  Sammy Almashat, M.D., M.P.H.,  Charles Preston, M.D., M.P.H., Timothy Waterman, B.S., Sidney Wolfe, M.D., Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry:  1991 – 2010, Public Citizen’s Health Research Group, December 16, 2010.

If you or a loved one have a whistleblower claim we would like to speak with you.   The Mulligan Law Firm is particularly interested in speaking to individuals with claims in Texas, Pennsylvania, California and Florida, but please call regardless of where you live in the United States or elsewhere if you believe you have a Qui Tam Whistleblower action to discuss with our attorneys. 

Any delay may cause you to lose your potential legal rights permanently.

Leave a Reply